COMMUNIQUÉS West-GlobeNewswire

Certa Therapeutics’ FT011 Granted US FDA Fast Track for the Treatment of Systemic Sclerosis

19/02/2024 - 09:00

MELBOURNE, Australia, Feb. 19, 2024 (GLOBE NEWSWIRE) -- Certa Therapeutics (Certa), a biotechnology company developing innovative precision therapies for patients with inflammatory and fibrotic diseases, today announces [...]

CMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa

19/02/2024 - 08:00

CMR Surgical hires industry leader to drive operations across Asia Pacific, the Middle East and Africa Sushobhan Dasgupta joins as President and Chief Commercial Officer for Asia Pacific, the Middle East and Africa [...]

BioPorto A/S to host investor meetings on 22 February 2024

19/02/2024 - 07:41

19 February 2024 News Release BioPorto A/S to host investor meetings on 22 February 2024 COPENHAGEN, DENMARK and BOSTON, Mass., 19 February 2024, BioPorto A/S (BioPorto or Company), an in vitro diagnostics company [...]

Vidac Pharma presents high efficacy in multiple solid tumor models for its next-generation cancer drug candidate and synergy with standard-of-care treatment in liver cancer organoids

19/02/2024 - 07:30

London (UK), February 19, 2024, 7:30 am CET – Vidac Pharma Holdings Plc. (Hamburg and Stuttgart: T9G; ISIN:GB00BM9XQ619; WKN: A3DTUQ), a clinical-stage oncology biopharmaceutical company pioneering a novel class of [...]

Vidac Pharma présente une efficacité élevée dans plusieurs modèles de tumeurs solides pour son candidat médicament anticancéreux de nouvelle génération, et une synergie avec le traitement standard des organoïdes du cancer du foie

19/02/2024 - 07:30

Londres (Royaume-Uni), 19 février 2024, 7:30 CET – Vidac Pharma Holding Plc (Hambourg et Stuttgart : T9G ; ISIN : GB00BM9XQ619 ; WKN : A3DTUQ) est une société biopharmaceutique d'oncologie de stade clinique, pionnière [...]

Ultimovacs Receives EMA Orphan Drug Designation for UV1 Cancer Vaccine for the Treatment of Mesothelioma

19/02/2024 - 07:00

The Orphan Drug Designation (ODD) from the European Medicines Agency (EMA) was granted based on results from the randomized Phase II clinical trial NIPU, which showed improved overall survival with UV1 in combination [...]

CARBIOS rallies players to promote textile circularity sector in the presence of M. Bruno Le Maire, Minister of Economy, Finance and Industrial and Digital Sovereignty

19/02/2024 - 06:45

CARBIOS rallies players to promote textile circularity sector in the presence of M. Bruno Le Maire, Minister of Economy, Finance and Industrial and Digital Sovereignty Clermont-Ferrand, France, 19 February 2024 (06.45am [...]

CARBIOS fédère les acteurs de la filière textile pour impulser la circularité du secteur en présence de M. Bruno Le Maire, Ministre de l’Economie, des Finances et de la Souveraineté industrielle et numérique

19/02/2024 - 06:45

CARBIOS fédère les acteurs de la filière textile pour impulser la circularité du secteur en présence de M. Bruno Le Maire, Ministre de l’Economie, des Finances et de la Souveraineté industrielle et numérique Clermont- [...]

New report exposes harmful impact of Ford government’s privatization scheme on local public hospitals: Health Coalition

18/02/2024 - 18:35

TORONTO, Feb. 18, 2024 (GLOBE NEWSWIRE) -- As the Ford government counters horror stories about unprecedented emergency department wait times, burgeoning deficits, and an unrelenting staffing crisis, it is running high- [...]

Nordic Naturals Issues Voluntary Recall of Baby's Vitamin D3 Liquid Due to Elevated Levels of Vitamin D3

17/02/2024 - 21:45

WATSONVILLE, Calif., Feb. 17, 2024 (GLOBE NEWSWIRE) -- Nordic Naturals is voluntarily recalling one lot of Nordic Naturals Baby’s Vitamin D3 Liquid, 0.76 fl. oz. (22.5 mL), 400 IU (10mcg) D3. This recall is being [...]

BRIGHT GREEN CORPORATION ANNOUNCES CHANGES TO BOARD OF DIRECTORS

17/02/2024 - 01:17

CEO, Groovy Singh appointed as a new member of the Company’s Board Founder, Lynn Stockwell, appointed as Chair of the Board of Directors Grants, New Mexico, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Bright Green Corporation ( [...]

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

16/02/2024 - 23:30

SAN CARLOS, Calif., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) ("Iovance" or the “Company”), a biotechnology company focused on innovating, developing, and delivering novel polyclonal [...]

R1 RCM to Present at Upcoming Investor Conferences

16/02/2024 - 23:00

MURRAY, Utah, Feb. 16, 2024 (GLOBE NEWSWIRE) -- R1 RCM Inc. (NASDAQ: RCM), a leading provider of technology-driven solutions that transform the patient experience and financial performance of healthcare providers, today [...]

Clover Health Announces Inducement Grant under Nasdaq Listing Rule 5635(c)(4)

16/02/2024 - 22:30

FRANKLIN, Tenn., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Clover Health Investments, Corp. (Nasdaq: CLOV) (“Clover” or the “Company”) announced today that effective February 16, 2024, the Talent and Compensation Committee of [...]

Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares

16/02/2024 - 22:20

BALA CYNWYD, Pa., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Larimar Therapeutics, Inc. (“Larimar”) (Nasdaq: LRMR), a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today [...]

Motus GI Holdings, Inc. Announces Adjournment of the February 16, 2024 Special Meeting of Stockholders

16/02/2024 - 22:15

FORT LAUDERDALE, Fla., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Motus GI Holdings, Inc. (“the Company”) (NASDAQ: MOTS), today announced that its special meeting of stockholders held on February 16, 2024 (the “Special Meeting [...]

Lifecore Biomedical, Inc. Announces Receipt of Nasdaq Notice of Delisting and Intention to Appeal

16/02/2024 - 22:05

Notice of Delisting Will Not Immediately Result in the Suspension or Delisting of the Company’s Securities CHASKA, Minn., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Lifecore Biomedical, Inc. (NASDAQ: LFCR) (the “Company”) [...]

Iovance Biotherapeutics to Host Conference Call and Webcast on Friday, February 16, 2024

16/02/2024 - 21:38

SAN CARLOS, Calif., Feb. 16, 2024 (GLOBE NEWSWIRE) -- Iovance Biotherapeutics, Inc. (NASDAQ: IOVA), a biotechnology company focused on innovating, developing, and delivering novel polyclonal tumor infiltrating [...]

Astra Plastic Surgery welcomes Dr. Pallavi Kumbla

16/02/2024 - 21:25

Acclaimed cosmetic and reconstructive surgeon now practicing at Alpharetta and Cumming locations ATLANTA, Feb. 16, 2024 (GLOBE NEWSWIRE) -- Astra Plastic Surgery, an acclaimed North Georgia-based cosmetic and [...]